These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24829203)

  • 1. TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis.
    Stengel A; Schnittger S; Weissmann S; Kuznia S; Kern W; Kohlmann A; Haferlach T; Haferlach C
    Blood; 2014 Jul; 124(2):251-8. PubMed ID: 24829203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very high TP53 mutation frequency of 93%.
    Mühlbacher V; Zenger M; Schnittger S; Weissmann S; Kunze F; Kohlmann A; Bellos F; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 Jun; 53(6):524-36. PubMed ID: 24619868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult Low-Hypodiploid Acute B-Lymphoblastic Leukemia With IKZF3 Deletion and TP53 Mutation: Comparison With Pediatric Patients.
    Fang M; Becker PS; Linenberger M; Eaton KD; Appelbaum FR; Dreyer Z; Airewele G; Redell M; Lopez-Terrada D; Patel A; Rabin KR; Lu X
    Am J Clin Pathol; 2015 Aug; 144(2):263-70. PubMed ID: 26185311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.
    Kanagal-Shamanna R; Jain P; Takahashi K; Short NJ; Tang G; Issa GC; Ravandi F; Garcia-Manero G; Yin CC; Luthra R; Patel KP; Khoury JD; Montalban-Bravo G; Sasaki K; Kadia TM; Borthakur G; Konopleva M; Jain N; Garris R; Pierce S; Wierda W; Estrov Z; Cortes J; O'Brien S; Kantarjian HM; Jabbour E
    Cancer; 2017 Oct; 123(19):3717-3724. PubMed ID: 28608976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
    Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
    Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYC rearranged B-cell neoplasms: Impact of genetics on classification.
    Haberl S; Haferlach T; Stengel A; Jeromin S; Kern W; Haferlach C
    Cancer Genet; 2016 Oct; 209(10):431-439. PubMed ID: 27810071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent and simultaneous epigenetic inactivation of TP53 pathway genes in acute lymphoblastic leukemia.
    Vilas-Zornoza A; Agirre X; Martín-Palanco V; Martín-Subero JI; San José-Eneriz E; Garate L; Álvarez S; Miranda E; Rodríguez-Otero P; Rifón J; Torres A; Calasanz MJ; Cruz Cigudosa J; Román-Gómez J; Prósper F
    PLoS One; 2011 Feb; 6(2):e17012. PubMed ID: 21386967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic abnormalities and TP53 and RAS gene profiles of childhood acute lymphoblastic leukemia in Morocco.
    Skhoun H; El Fessikh M; El Alaoui Al Abdallaoui M; Khattab M; Belkhayat A; Chebihi ZT; Hassani A; Abilkassem R; Agadr A; Dakka N; El Baghdadi J
    Arch Pediatr; 2024 May; 31(4):238-244. PubMed ID: 38679547
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Comeaux EQ; Mullighan CG
    Cold Spring Harb Perspect Med; 2017 Mar; 7(3):. PubMed ID: 28003275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 alterations in relapsed childhood acute lymphoblastic leukemia.
    Yu CH; Chang WT; Jou ST; Lin TK; Chang YH; Lin CY; Lin KH; Lu MY; Chen SH; Wu KH; Wang SC; Chang HH; Su YN; Hung CC; Lin DT; Chen HY; Yang YL
    Cancer Sci; 2020 Jan; 111(1):229-238. PubMed ID: 31729120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of cytogenetic findings at diagnosis and in remission in childhood and adult acute lymphoblastic leukemia: experience from India.
    Amare P; Gladstone B; Varghese C; Pai S; Advani S
    Cancer Genet Cytogenet; 1999 Apr; 110(1):44-53. PubMed ID: 10198622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
    Hof J; Krentz S; van Schewick C; Körner G; Shalapour S; Rhein P; Karawajew L; Ludwig WD; Seeger K; Henze G; von Stackelberg A; Hagemeier C; Eckert C; Kirschner-Schwabe R
    J Clin Oncol; 2011 Aug; 29(23):3185-93. PubMed ID: 21747090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome.
    Falk IJ; Willander K; Chaireti R; Lund J; Nahi H; Hermanson M; Gréen H; Lotfi K; Söderkvist P
    Eur J Haematol; 2015 Apr; 94(4):355-62. PubMed ID: 25156865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the type of 5q loss with complex karyotype, clonal evolution, TP53 mutation status, and prognosis in acute myeloid leukemia and myelodysplastic syndrome.
    Volkert S; Kohlmann A; Schnittger S; Kern W; Haferlach T; Haferlach C
    Genes Chromosomes Cancer; 2014 May; 53(5):402-10. PubMed ID: 24493299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep targeted sequencing of
    Brieghel C; Kinalis S; Yde CW; Schmidt AY; Jønson L; Andersen MA; da Cunha-Bang C; Pedersen LB; Geisler CH; Nielsen FC; Niemann CU
    Haematologica; 2019 Apr; 104(4):789-796. PubMed ID: 30514802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic TP53-Mutant Clonal Hematopoiesis.
    Kim R; Bergugnat H; Larcher L; Duchmann M; Passet M; Gachet S; Cuccuini W; Lafage-Pochitaloff M; Pastoret C; Grardel N; Asnafi V; Schäfer BW; Delabesse E; Itzykson R; Adès L; Hicheri Y; Chalandon Y; Graux C; Chevallier P; Hunault M; Leguay T; Huguet F; Lhéritier V; Dombret H; Soulier J; Rousselot P; Boissel N; Clappier E
    Blood Cancer Discov; 2023 Mar; 4(2):134-149. PubMed ID: 36630200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A population-based cytogenetic study of adults with acute lymphoblastic leukemia.
    Moorman AV; Chilton L; Wilkinson J; Ensor HM; Bown N; Proctor SJ
    Blood; 2010 Jan; 115(2):206-14. PubMed ID: 19897583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survival.
    Salmoiraghi S; Montalvo ML; Ubiali G; Tosi M; Peruta B; Zanghi P; Oldani E; Boschini C; Kohlmann A; Bungaro S; Intermesoli T; Terruzzi E; Angelucci E; Cavattoni I; Ciceri F; Bassan R; Rambaldi A; Spinelli O
    Haematologica; 2016 Jun; 101(6):e245-8. PubMed ID: 26992948
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure and significance of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia.
    Piskunova IS; Obukhova TN; Parovichnikova EN; Kulikov SM; Troitskaya VV; Gavrilina OA; Savchenko VG
    Ter Arkh; 2018 Aug; 90(7):30-37. PubMed ID: 30701920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC Expression Is Associated With p53 Expression and TP53 Aberration and Predicts Poor Overall Survival in Acute Lymphoblastic Leukemia/Lymphoma.
    Gao L; Harbaugh B; Parr K; Patel P; Golem S; Zhang D; Woodroof J; Cui W
    Am J Clin Pathol; 2022 Jan; 157(1):119-129. PubMed ID: 34528662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.